Market Research Logo

United States Electrophysiology Devices Market Outlook to 2025

United States Electrophysiology Devices Market Outlook to 2025

Summary

GlobalData’s new report, United States Electrophysiology Devices Market Outlook to 2025, provides key market data on the United States Electrophysiology Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments -Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters and Electrophysiology Lab Systems.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Electrophysiology Devices market segments - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters and Electrophysiology Lab Systems.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Electrophysiology Devices market.
  • Global corporate-level profiles of key companies operating within the United States Electrophysiology Devices market.
  • Key players covered include Abbott Laboratories, Medtronic plc, Biosense Webster Inc, and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Electrophysiology Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Electrophysiology Devices Market, United States
3.1 Electrophysiology Devices Market, United States, Revenue ($m), 2015-2025
3.1.1 Electrophysiology Ablation Catheters Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.2 Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.3 Electrophysiology Lab Systems Market, United States, Revenue ($m), by Segment, 2015-2025
3.2 Electrophysiology Devices Market, United States, Volume (Units), 2015-2025
3.2.1 Electrophysiology Ablation Catheters Market, United States, Volume (Units), by Segment, 2015-2025
3.2.2 Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), by Segment, 2015-2025
3.2.3 Electrophysiology Lab Systems Market, United States, Volume (Units), by Segment, 2015-2025
3.3 Electrophysiology Devices Market, United States, Average Price ($), 2015-2025
3.4 Electrophysiology Devices Market, United States, Distribution Share by Revenue ($m), 2017
3.5 Electrophysiology Devices Market, United States, Company Share by Revenue ($m), 2017
4 Overview of Key Companies in United States, Electrophysiology Devices Market
4.1 Biosense Webster Inc
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Medtronic Plc
4.3.1 Company Overview
4.4 Boston Scientific Corp
4.4.1 Company Overview
4.5 Micropace EP Inc.
4.5.1 Company Overview
4.6 Fischer Imaging Corp
4.6.1 Company Overview
5 Electrophysiology Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 NN Acquires Bridgemedica
6.1.2 Becton, Dickinson Acquires C. R. Bard for USD24 Billion
6.2 Debt Offerings
6.2.1 Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028
6.3 Equity Offerings
6.3.1 Corindus Vascular Robotics to Raise USD25 Million in Private Placement of Preferred Shares and Warrants
6.3.2 BioSig Technologies Raises USD4.5 Million in Private Placement of Shares
6.3.3 MC10 Raises Funds through Private Placement of Shares
6.3.4 MRI Interventions Raises USD13.3 Million in Private Placement of Units
6.3.5 BioSig Technologies Raises USD4.3 Million in Private Placement of Shares
6.4 Venture Financing
6.4.1 MC10 Raises USD15 Million in Venture Financing
6.4.2 BioSig Technologies Raises USD2 Million in Venture Financing
6.4.3 MC10 Raises Additional USD2 Million in Venture Financing
6.4.4 MC10 Raises USD7.3 Million in Venture Financing
6.4.5 BioSig Technologies Raises USD1.6 Million in Venture Financing
7 Recent Developments
7.1 Corporate Communications
7.1.1 Mar 05, 2018: AblaCor Appoints Lawrence Rosenthal To Its Scientific Advisory Board
7.1.2 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman
7.1.3 Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors
7.1.4 Jan 03, 2018: BioSig Technologies Appoints New CFO to Facilitate Growth Trajectory
7.1.5 Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer
7.1.6 Nov 14, 2017: BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission
7.1.7 Nov 10, 2017: IP veteran Andrew Filler joins BioSig Technologies’ Board of Directors
7.1.8 Oct 25, 2017: Harvard Bioscience Appoints Katherine Eade and Thomas Loewald to the Board of Directors
7.1.9 Oct 11, 2017: BioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization Officer
7.1.10 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
7.1.11 Sep 11, 2017: An opportunity to evaluate and speed-up new projects - Meet GE Healthcare at the Uppsala BIO booth
7.1.12 Aug 08, 2017: John K. Bakewell Joins Corindus Vascular Robotics Board of Directors
7.1.13 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe
7.1.14 Jul 18, 2017: AtriCure Announces Hiring of Chief Technology Officer
7.1.15 Jul 17, 2017: Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer
7.1.16 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery
7.1.17 Jun 07, 2017: Harvard Bioscience Elects James Green as Chairman of Board of Directors
7.1.18 May 31, 2017: BioSig Technologies Welcomes Natasha Russkina as Managing Director, Europe
7.1.19 May 26, 2017: Merit Medical Announces Appointment of New Director
7.2 Financial Announcements
7.2.1 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results
7.2.2 Mar 14, 2018: Corindus Reports Fourth Quarter and Full Year 2017 Results
7.2.3 Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results
7.2.4 Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results
7.2.5 Feb 22, 2018: Integer Holdings Reports Results for Fourth Quarter and Full Year 2017
7.2.6 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
7.2.7 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
7.2.8 Jan 08, 2018: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017
7.2.9 Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results
7.2.10 Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results
7.2.11 Nov 07, 2017: Corindus Vascular Robotics Reports Third Quarter 2017 Results
7.2.12 Nov 01, 2017: AtriCure Reports Third Quarter 2017 Financial Results
7.2.13 Oct 26, 2017: Harvard Bioscience Reports Third Quarter 2017 Financial Results
7.2.14 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
7.2.15 Oct 26, 2017: Integer Holdings Reports Third Quarter 2017 Results
7.2.16 Oct 25, 2017: Bard Announces Third Quarter Results
7.2.17 Oct 25, 2017: Merit Medical Reports Results for Third Quarter 2017
7.2.18 Oct 16, 2017: Kura Oncology Announces Late-Breaking Presentations for Tipifarnib in HRAS Mutant Squamous Head and Neck Cancer at Upcoming AACR-NCI-EORTC International Conference
7.2.19 Sep 26, 2017: DFB Soria Gives Update on Enrollment in Phase 2 Clinical Trial of SOR007 (Nanoparticle Paclitaxel) Ointment for Actinic Keratosis (AK)
7.2.20 Sep 09, 2017: Teva Showcases Data Demonstrating Potential of Fremanezumab to Address Significant Unmet Need in Patients with Chronic and Episodic Migraine
7.2.21 Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results
7.2.22 Aug 08, 2017: Corindus Vascular Robotics Reports Second Quarter 2017 Results
7.2.23 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
7.2.24 Jul 27, 2017: AtriCure Reports Second Quarter 2017 Financial Results
7.2.25 Jul 27, 2017: Harvard Bioscience Reports Second Quarter 2017 Financial Results
7.2.26 Jul 27, 2017: Integer Holdings Reports Second Quarter 2017 Results
7.2.27 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance
7.2.28 May 09, 2017: Corindus Vascular Robotics Reports First Quarter 2017 Results
7.2.29 May 08, 2017: Integer Holdings Reports First Quarter 2017 Results
7.2.30 May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results
7.2.31 May 04, 2017: AtriCure Reports First Quarter 2017 Financial Results
7.2.32 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017
7.2.33 Apr 27, 2017: Harvard Bioscience Reports First Quarter 2017 Financial Results
7.2.34 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017
7.2.35 Apr 23, 2017: Bard Announces First Quarter Results
7.2.36 Apr 17, 2017: Lixte Biotechnology's Protein Phosphatase 2A Inhibitor, LB-100, Reported to be a Potentiator of Immunotherapy in an Animal Model
7.3 Other Significant Developments
7.3.1 Mar 06, 2018: V ClinBio Partners with Camargo for Strategic 505(b)(2) Development of CLX-103
7.3.2 Feb 22, 2018: Integer Announces Strategy Focused on Portfolio Management and Operational Excellence; Aligns Senior Management to Execute Strategic Imperatives
7.3.3 Dec 21, 2017: BioSig Technologies Issues Shareholder Letter for 2017
7.3.4 Nov 02, 2017: BioSig Technologies Partners with Sherpa Technology Group
7.3.5 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
7.3.6 Jun 01, 2017: Hitachi Healthcare Americas Partners with the WVU Heart and Vascular Institute to Advance the Evaluation of Left Ventricular Mechanical Function
7.4 Strategy And Business Planning
7.4.1 Nov 20, 2017: DBV Technologies Announces Positive Topline Safety Results from REALISE Phase III Trial of Viaskin Peanut for the Treatment of Peanut-Allergic Patients
7.4.2 Sep 11, 2017: An opportunity to evaluate and speed-up new projects - Meet GE Healthcare at the Uppsala BIO booth
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
1.1 List of Tables
Table 1: Electrophysiology Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Electrophysiology Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Electrophysiology Ablation Catheters Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 4: Electrophysiology Ablation Catheters Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 5: Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 6: Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 7: Electrophysiology Lab Systems Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 8: Electrophysiology Lab Systems Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 9: Electrophysiology Devices Market, United States, Volume (Units), 2015-2020
Table 10: Electrophysiology Devices Market, United States, Volume (Units), 2021-2025
Table 11: Electrophysiology Ablation Catheters Market, United States, Volume (Units), 2015-2020
Table 12: Electrophysiology Ablation Catheters Market, United States, Volume (Units), 2021-2025
Table 13: Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), 2015-2020
Table 14: Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), 2021-2025
Table 15: Electrophysiology Lab Systems Market, United States, Volume (Units), 2015-2020
Table 16: Electrophysiology Lab Systems Market, United States, Volume (Units), 2021-2025
Table 19: Electrophysiology Devices Market, United States, Average Price ($), 2015-2020
Table 20: Electrophysiology Devices Market, United States, Average Price ($), 2021-2025
Table 21: Electrophysiology Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017
Table 22: Electrophysiology Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2017
Table 23: Electrophysiology Devices Market Pipeline Products
Table 24: NN Acquires Bridgemedica
Table 25: Becton, Dickinson Acquires C. R. Bard for USD24 Billion
Table 26: Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028
Table 27: Corindus Vascular Robotics to Raise USD25 Million in Private Placement of Preferred Shares and Warrants
Table 28: BioSig Technologies Raises USD4.5 Million in Private Placement of Shares
Table 29: MC10 Raises Funds through Private Placement of Shares
Table 30: MRI Interventions Raises USD13.3 Million in Private Placement of Units
Table 31: BioSig Technologies Raises USD4.3 Million in Private Placement of Shares
Table 32: MC10 Raises USD15 Million in Venture Financing
Table 33: BioSig Technologies Raises USD2 Million in Venture Financing
Table 34: MC10 Raises Additional USD2 Million in Venture Financing
Table 35: MC10 Raises USD7.3 Million in Venture Financing
Table 36: BioSig Technologies Raises USD1.6 Million in Venture Financing
Table 44: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country
1.2 List of Figures
Figure 1: Electrophysiology Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Electrophysiology Ablation Catheters Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 4: Electrophysiology Lab Systems Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 5: Electrophysiology Devices Market, United States, Volume (Units), 2015-2025
Figure 6: Electrophysiology Ablation Catheters Market, United States, Volume (Units), 2015-2025
Figure 7: Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), 2015-2025
Figure 8: Electrophysiology Lab Systems Market, United States, Volume (Units), 2015-2025
Figure 9: Electrophysiology Devices Market, United States, Company Share (%) 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report